- Home
- REPL vs GPRK Comparison
REPL vs GPRK Comparison
Compare REPL & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REPL | GPRK |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 608.0M |
| IPO Year | 2018 | 2009 |
Fundamental Metrics
Financial Performance| Metric | REPL | GPRK |
|---|---|---|
| Price | $1.96 | $8.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $5.67 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 7.3M | 1.2M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | ★ 5.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $39.45 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $5.75 |
| 52 Week High | $13.24 | $10.34 |
Technical Indicators
Market Signals| Indicator | REPL | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 23.87 | 47.92 |
| Support Level | $1.50 | $7.87 |
| Resistance Level | $8.82 | $10.18 |
| Average True Range (ATR) | 0.75 | 0.50 |
| MACD | -0.42 | -0.05 |
| Stochastic Oscillator | 6.05 | 40.36 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About GPRK Geopark Ltd
GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.